A DOT violation does not end when the test result is reported. For employers, the next steps determine whether the employee can legally return to safety-sensitive work and whether the company can demonstrate compliance during an audit. This guide to return to duty process requirements explains the actions DOT-regulated employers must coordinate after a drug or alcohol violation.

The process is governed primarily by 49 CFR Part 40, with agency-specific requirements that may also apply. It is not a disciplinary process, and it is not the same as a company’s decision to retain or rehire an employee. The DOT process establishes whether a person is eligible to perform safety-sensitive duties again. The employer still retains its own employment decision rights, subject to applicable law, contracts, and company policy.

What Triggers the Return-to-Duty Process?

The return-to-duty process applies when an employee violates a DOT drug and alcohol testing regulation. Common triggers include a verified positive drug test, an alcohol confirmation result of 0.04 or higher, a refusal to test, an adulterated or substituted specimen, or other conduct classified as a refusal under Part 40.

Once a violation occurs, the employee must be immediately removed from DOT safety-sensitive duties. This includes driving a commercial motor vehicle, performing covered aviation functions, operating rail equipment, or conducting other work regulated by FMCSA, FAA, FTA, FRA, PHMSA, or USCG rules.

Removal is not optional while the violation is unresolved. Employers should document the date, time, reason for removal, and the duties from which the employee was removed. Clear records protect the employee, the employer, and the integrity of the testing program.

The Guide to Return to Duty Process: Key Steps

A compliant process follows a defined sequence. Trying to shortcut that sequence can create a serious compliance issue, even if the employee has completed treatment or produced a negative test elsewhere.

1. Provide a Qualified SAP Referral

After a violation, the employer must provide the employee with a list of qualified Substance Abuse Professionals, or SAPs. A SAP is not simply a counselor or treatment provider. The SAP must meet DOT qualification requirements and be knowledgeable about Part 40 procedures.

The employer does not select the treatment plan or direct the SAP’s clinical judgment. The SAP conducts an initial face-to-face or approved remote evaluation and recommends education and/or treatment based on the employee’s needs. Employers should confirm that the referral list is current and that the professional is qualified to perform DOT SAP evaluations.

The employee is generally responsible for following through with the SAP process. However, prompt communication from the employer helps avoid confusion about the employee’s status, available benefits, and the conditions that must be met before a return-to-duty test can be scheduled.

2. Keep the Employee Out of Safety-Sensitive Work

The employee cannot perform any DOT safety-sensitive function until every required step is complete. This restriction remains in place while the employee attends education or treatment and while awaiting the follow-up SAP evaluation.

An employer may assign non-safety-sensitive duties if company policy permits and the work does not fall under a DOT-covered function. Whether to offer alternate work, unpaid leave, or continued employment is a business and employment-law decision. It does not change the federal testing requirements.

For multi-agency employers, carefully identify all covered roles. An employee may not return to one DOT safety-sensitive position while still prohibited from another covered function under the same unresolved violation.

3. Receive the SAP’s Follow-Up Evaluation Report

After the employee completes the recommended education or treatment, the employee returns to the same SAP for a follow-up evaluation. The SAP determines whether the employee has demonstrated successful compliance with the recommendation.

If the SAP is satisfied, the SAP provides the employer with a written report stating that the employee is eligible for return-to-duty testing. This report is a required checkpoint. Completion of a treatment program alone does not authorize testing or a return to work.

The SAP also develops a follow-up testing plan. That plan directs the employer to conduct a minimum of six unannounced follow-up tests during the first 12 months after the employee returns to safety-sensitive work. The SAP may require more than six tests and may extend testing for up to 60 months.

4. Schedule a DOT Return-to-Duty Test

Once the employer receives the SAP’s report, it may schedule the return-to-duty test. For drug testing, the return-to-duty collection must be conducted under direct observation. This is a specific DOT collection procedure and should be coordinated with a collection site that can perform observed collections correctly.

The employee must receive a verified negative drug test result before returning to a DOT safety-sensitive position. For alcohol testing, the employee must have a result below 0.02 before performing safety-sensitive duties.

A negative result from a non-DOT test, a pre-employment test, or a test completed before the SAP’s eligibility report does not replace the required DOT return-to-duty test. The timing, test type, chain of custody, and result reporting all matter.

5. Complete Agency-Specific Reporting and Queries

FMCSA-regulated employers have additional Clearinghouse responsibilities. Before allowing a CDL driver to return to safety-sensitive work after a drug or alcohol violation, the employer must ensure the driver’s Clearinghouse record supports the return. Required reports and full queries must be handled at the correct points in the process.

This is an area where administrative errors are common. A driver may have completed the SAP process and a return-to-duty test, but the employer must still complete the applicable Clearinghouse actions before dispatching the driver. Employers should maintain a clear workflow that connects the MRO, SAP, C/TPA, employer representative, and driver.

Other DOT agencies have their own records and program requirements. A testing provider or C/TPA can help coordinate testing and documentation, but the employer remains responsible for ensuring the program is administered correctly.

Managing the Follow-Up Testing Plan

The return-to-duty test is not the final test in the process. Follow-up testing begins only after the employee actually resumes DOT safety-sensitive work. It must be unannounced, and it is separate from the employee’s regular random testing obligations.

The employer must carry out the SAP’s follow-up plan exactly as written. Do not substitute random tests for required follow-up tests, and do not allow a supervisor or manager to decide that enough testing has occurred. Only the SAP can modify the follow-up plan.

Employees who move to another DOT employer remain subject to the SAP’s plan. The former employer should preserve the required records, and the new employer must obtain the necessary information to continue the follow-up testing schedule. This is especially important for drivers, owner-operators, and workers who change contractors or operating locations.

Documentation That Supports Compliance

A defensible return-to-duty file should show the complete timeline from violation through follow-up testing. Keep the violation record, proof of removal from safety-sensitive work, SAP referral information, SAP reports, return-to-duty test documentation, Clearinghouse records when applicable, and follow-up test records.

Confidentiality matters. Drug and alcohol testing records must be protected and shared only with authorized parties. Supervisors should receive only the information needed to manage work status and testing logistics, not clinical details from the SAP process.

Record retention periods vary based on the type of result and document. Employers should use a centralized, controlled recordkeeping process rather than relying on scattered email files, individual manager notes, or verbal updates.

Common Employer Errors to Avoid

The most costly mistakes usually come from good intentions combined with incomplete process control. Allowing an employee back after treatment but before a verified negative return-to-duty result is a violation. So is scheduling a test before receiving the SAP’s compliance report.

Employers also run into trouble when they fail to conduct the return-to-duty drug collection under direct observation, forget to activate follow-up testing after the employee returns, or treat a follow-up test as part of the random pool. For FMCSA employers, missed Clearinghouse steps can delay a driver’s return and expose the company to enforcement risk.

A written workflow, trained supervisors, dependable collection access, and responsive C/TPA support reduce these risks. The process may involve several parties, but the employer needs one clear view of what has been completed and what remains outstanding.

A return-to-duty case should be managed with urgency, but never with shortcuts. When each step is documented, verified, and scheduled correctly, employers can protect public safety while giving eligible employees a clear path back to regulated work.